NCT05038995

Brief Summary

This study aimed to survey the growth of children who were on elimination diet due to cow milk allergy in Turkey. 0-5 year aged children diagnosed with cow's milk allergy (CMA) and healthy age-sex-matched children as the control group was planned for inclusion. Participants will be included in the study by consecutive sampling. The anthropometry measurements (height-for-age \[HFA\], weight-for-age \[WFA\], and weight-for-height \[WtHt\]) will be evaluated according to the Z-score using the WHO ANTHRO \[Z-score = Patient's value - Average value / Standard Deviation (SD)\]. The Z-score (SDS) in the average child by age was "0".

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

September 9, 2021

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 20, 2021

Completed
Last Updated

September 9, 2021

Status Verified

August 1, 2021

Enrollment Period

6 months

First QC Date

August 19, 2021

Last Update Submit

September 3, 2021

Conditions

Keywords

Cow milk allergyElimination dietAnthropometryGrowth status

Outcome Measures

Primary Outcomes (12)

  • Body weight in kilograms-T0

    Body weight (kg)

    One month prior to the diagnosis of CMA

  • Body weight in kilograms-T1

    Body weight (kg)

    On the 3-month of CME diet

  • Body weight in kilograms-T2

    Body weight (kg)

    Three months after the end of the CME diet

  • Body weight in kilograms-T3

    Body weight (kg)

    The last examination date of the patient after 3rd month control after CME diet

  • Height in centimeters-T0

    Height (cm)

    One month prior to the diagnosis of CMA

  • Height in centimeters-T1

    Height (cm)

    On the 3-month of CME diet

  • Height in centimeters-T2

    Height (cm)

    Three months after the end of the CME diet

  • Height in centimeters-T3

    Height (cm)

    The last examination date of the patient after 3rd month control after CME diet

  • Head circumference in centimeters-T0

    Head circumference (cm)

    One month prior to the diagnosis of CMA

  • Head circumference in centimeters-T1

    Head circumference (cm)

    On the 3-month of CME diet

  • Head circumference in centimeters-T2

    Head circumference (cm)

    Three months after the end of the CME diet

  • Head circumference in centimeters-T3

    Head circumference (cm)

    The last examination date of the patient after 3rd month control after CME diet

Secondary Outcomes (13)

  • Dietary intake

    The last examination date of the patient after 3rd month control after CME diet

  • Blood measurements-Hemoglobin

    The last examination date of the patient after 3rd month control after CME diet

  • Blood measurements-Sodium

    The last examination date of the patient after 3rd month control after CME diet

  • Blood measurements-Potassium

    The last examination date of the patient after 3rd month control after CME diet

  • Blood measurements-Albumin

    The last examination date of the patient after 3rd month control after CME diet

  • +8 more secondary outcomes

Study Arms (2)

Cow milk elimination group

The CME children will be eligible for the study if they (1) had a diagnosis of CMA by OFC, except children with known anaphylaxis (2) those on a CME diet or a specialized infant formula for at least three months (3) had reintroduced cow's milk for at least three months ago. Children who excluded other foods in addition to cows' milk in the first four years of life for ≥ three months and who currently introduced these foods for at least ≥ three months will be also enrolled in the CME group.

Healthy group

Healthy children will ve eligible for the study if they (1) did not have CMA and other allergic diseases (2) who had never been on a diet throughout their lives.

Eligibility Criteria

Age1 Month - 5 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Pediatric Allergy Department Outpatient Clinic and Healthy Child Outpatient Clinic

You may qualify if:

  • had a diagnosis of CMA by OFC, except children with known anaphylaxis
  • those on a CME diet or a specialized infant formula for at least three months
  • had reintroduced cow's milk for at least three months ago.
  • Children who excluded other foods in addition to cows' milk in the first four years of life for ≥ three months and who currently introduced these foods for at least ≥ three months were also enrolled in the CME group.
  • did not have CMA and other allergic diseases
  • who had never been on a diet throughout their lives.

You may not qualify if:

  • Known acute (e.g., influenza) or chronic (e.g., diabetes, immune deficiencies ) diseases,
  • history of systemic steroid use \> 0.5 mg/kg for more than one week in their life,
  • recurrent infections within the last three months,
  • food restriction other than food allergy (e.g., vegan, vegetarian),
  • moderate to severe asthma, and other medical or surgical conditions which might affect nutrition and growth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences, Gulhane Education and Research Hospital

Ankara, Turkey (Türkiye)

RECRUITING

Related Links

MeSH Terms

Conditions

Milk Hypersensitivity

Condition Hierarchy (Ancestors)

Food HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Nazli Ercan, MD

    University of Health Sciences Turkey, Gulhane Education and Research Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

August 19, 2021

First Posted

September 9, 2021

Study Start

April 1, 2021

Primary Completion

September 20, 2021

Study Completion

September 20, 2021

Last Updated

September 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations